Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	6.33T -10.6%
Revenue (ttm)	2.25T +11.6%
Net Income	66.57B -2.5%
EPS	734.97
Shares Out	90.57M
PE Ratio	95.11
Forward PE	n/a
Dividend	909.09 (1.30%)
Ex-Dividend Date	n/a

Volume	50,120
Average Volume	16,473
Open	68,500
Previous Close	70,000
Day's Range	68,000 - 70,000
52-Week Range	68,000 - 86,800
Beta	0.25
RSI	48.13
Earnings Date	Jan 22, 2026

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.